期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 227, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2021.113931
关键词
5-HT7; Aminotriazine; lcap; Medicinal chemistry; Microvave synthesis
资金
- PLG infrastructure (Prometheus, ACCCYFRONET, AGH) [drugdesign4]
Arylpiperazine derivatives with dual 5-HT1A/5-HT7 action are widely used for treating central nervous system diseases; two newly designed 5-HT7 ligands showed good metabolic stability and different hepatotoxicity performances.
Owing to their multifunctional pharmacological profiles (including dual 5-HT1A/5-HT7 action), arylpiperazine derivatives are widely used for treating central nervous system diseases including the depression or neuropathic pain. Herein we describe the design, synthesis and evaluation of biological activity of novel 5-HT7 ligands derived of 2,4,6-triamino-1,3,5-triazine. The studied compounds showed affinity and high selectively towards 5-HT7 receptor with the two most active compounds 34 (K-i = 61 nM), 22 (K-i = 109 nM) showing good metabolic stability and moderate affinity to CYP3A4 isoenzyme. Compound 22 had high hepatotoxicity at a concentration below 50 mu M, while compound 34 showed low hepatotoxicity even at a concentration above 50 mu M. (C) 2021 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据